ReviewFrontiers in immunology2023

Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.

Ruixia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.